{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T02:05:57Z","timestamp":1778637957026,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ijcard.2024.132338","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T16:29:42Z","timestamp":1719937782000},"page":"132338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Preadmission metformin use increased the incidence of hyperlactatemia at admission and 30-day in-hospital mortality among T2D patients with heart disease at high risk of hypoxia"],"prefix":"10.1016","volume":"412","author":[{"given":"Le","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongsu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahui","family":"Lao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinglong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2024.132338_bb0005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12929-020-00658-7","article-title":"Pathophysiological implications of hypoxia in human diseases","volume":"27","author":"Chen","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ijcard.2024.132338_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0299-y","article-title":"Hypoxia signaling in human diseases and therapeutic targets","volume":"51","author":"Lee","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ijcard.2024.132338_bb0015","first-page":"10","article-title":"Clinical significance of serum lactate in acute myocardial infarction: a cardiac magnetic resonance imaging study","author":"Park","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijcard.2024.132338_bb0020","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s12012-020-09563-9","article-title":"The effect of high lactate level on mortality in acute heart failure patients with reduced ejection fraction without cardiogenic shock","volume":"20","author":"Uyar","year":"2020","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.ijcard.2024.132338_bb0025","article-title":"The relationship between the utilization of arterial blood gas analysis and Rehospitalization in heart failure: a retrospective cohort study","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Cardiovasc Med."},{"key":"10.1016\/j.ijcard.2024.132338_bb0030","doi-asserted-by":"crossref","DOI":"10.4081\/hi.2011.e8","article-title":"Does high-dose metformin cause lactic acidosis in type 2 diabetic patients after CABG surgery? A double blind randomized clinical trial","volume":"6","author":"Baradari","year":"2011","journal-title":"Heart Int."},{"key":"10.1016\/j.ijcard.2024.132338_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155160","article-title":"Metformin and the heart: update on mechanisms of cardiovascular protection with special reference to comorbid type 2 diabetes and heart failure","volume":"130","author":"Schernthaner","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.ijcard.2024.132338_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2019.107474","article-title":"Metformin is associated with increase in lactate level in elderly patients with type 2 diabetes and CKD stage 3: a case-control study","volume":"34","author":"Gosmanova","year":"2020","journal-title":"J. Diabetes Complications"},{"key":"10.1016\/j.ijcard.2024.132338_bb0045","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s40261-017-0564-6","article-title":"Lactate levels with chronic metformin use: a narrative review","volume":"37","author":"Huang","year":"2017","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.ijcard.2024.132338_bb0050","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1007\/s00125-010-1906-6","article-title":"Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study","volume":"53","author":"Andersson","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.ijcard.2024.132338_bb0055","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.2337\/diacare.28.10.2345","article-title":"Improved clinical outcomes associated with metformin in patients with diabetes and heart failure","volume":"28","author":"Eurich","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2024.132338_bb0060","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1161\/CIRCHEARTFAILURE.112.000162","article-title":"Comparative safety and effectiveness of metformin in patients with diabetes mellitus and heart failure: systematic review of observational studies involving 34,000 patients","volume":"6","author":"Eurich","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2024.132338_bb0065","first-page":"300","article-title":"Metformin does not induce hyperlactatemia in patients admitted to internal medicine Ward","volume":"19","author":"Koren","year":"2017","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.ijcard.2024.132338_bb0070","first-page":"6","article-title":"Comparative safety of sulfonylurea and metformin monotherapy on the risk of heart failure: a cohort study","author":"Roumie","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcard.2024.132338_bb0075","doi-asserted-by":"crossref","first-page":"390","DOI":"10.7326\/0003-4819-105-3-390","article-title":"Indications for arterial blood gas analysis","volume":"105","author":"Raffin","year":"1986","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2024.132338_bb0080","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4330\/wjc.v7.i8.483","article-title":"Clinical significance of lactate in acute cardiac patients","volume":"7","author":"Lazzeri","year":"2015","journal-title":"World J. Cardiol."},{"key":"10.1016\/j.ijcard.2024.132338_bb0085","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/MCA.0000000000000674","article-title":"Association between admission lactate levels and mortality in patients with acute coronary syndrome: a retrospective cohort study","volume":"30","author":"Liang","year":"2019","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.ijcard.2024.132338_bb0090","doi-asserted-by":"crossref","first-page":"1015298","DOI":"10.3389\/fendo.2022.1015298","article-title":"Outcomes of hyperlactatemia on admission in critically ill patients with acute myocardial infarction: a retrospective study from MIMIC-IV","volume":"13","author":"Lu","year":"2022","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"Suppl. 1","key":"10.1016\/j.ijcard.2024.132338_bb0095","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/imj.14153","article-title":"Extended dual antiplatelet therapy for Asian patients with acute coronary syndrome: expert recommendations","volume":"49","author":"Chen","year":"2019","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.ijcard.2024.132338_bb0100","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2362.2010.02447.x","article-title":"Clinical features of heart failure hospitalization in younger and elderly patients in Taiwan","volume":"41","author":"Tseng","year":"2011","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.ijcard.2024.132338_bb0105","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1532-5415.2010.02755.x","article-title":"The age- and sex-specific incidence and medical expenses of heart failure hospitalization in 2005 in Taiwan: a study using data from the National Health Insurance","volume":"58","author":"Tseng","year":"2010","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.ijcard.2024.132338_bb0110","first-page":"11","article-title":"Effects of metformin in heart failure: from pathophysiological rationale to clinical evidence","author":"Salvatore","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ijcard.2024.132338_bb0115","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12933-020-01202-5","article-title":"Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus","volume":"20","author":"Li","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ijcard.2024.132338_bb0120","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.coph.2020.10.018","article-title":"Metformin: still the sweet spot for CV protection in diabetes","volume":"54","author":"Rena","year":"2020","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ijcard.2024.132338_bb0125","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12933-019-0900-7","article-title":"Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis","volume":"18","author":"Han","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ijcard.2024.132338_bb0130","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3122\/jabfm.2015.06.150064","article-title":"Variations in metformin prescribing for type 2 diabetes","volume":"28","author":"Goldberg","year":"2015","journal-title":"J. Am. Board Fam. Med."},{"key":"10.1016\/j.ijcard.2024.132338_bb0135","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.jdiacomp.2015.06.001","article-title":"Adverse event notifications implicating metformin with lactic acidosis in Australia","volume":"29","author":"Huang","year":"2015","journal-title":"J. Diabetes Complications"},{"key":"10.1016\/j.ijcard.2024.132338_bb0140","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM199801223380415","article-title":"Lactic acidosis in patients with diabetes treated with metformin","volume":"338","author":"Misbin","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2024.132338_bb0145","first-page":"CD002967","article-title":"Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus","author":"Salpeter","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ijcard.2024.132338_bb0150","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12933-019-0972-4","article-title":"Metformin use and cardiovascular outcomes after acute myocardial infarction in patients with type 2 diabetes: a cohort study","volume":"18","author":"Bromage","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ijcard.2024.132338_bb0155","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13779","article-title":"Regulation of heart rate in vertebrates during hypoxia: a comparative overview","volume":"234","author":"Joyce","year":"2022","journal-title":"Acta Physiol (Oxf.)"},{"key":"10.1016\/j.ijcard.2024.132338_bb0160","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/dom.13663","article-title":"Glycaemic control after treatment intensification in patients with type 2 diabetes uncontrolled on two or more non-insulin antidiabetic drugs in a real-world setting","volume":"21","author":"Canivell","year":"2019","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ijcard.2024.132338_bb0165","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s40265-020-01279-y","article-title":"Third-line antidiabetic therapy intensification patterns and Glycaemic control in patients with type 2 diabetes in the USA: a Real-world study","volume":"80","author":"Koye","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.ijcard.2024.132338_bb0170","first-page":"31","article-title":"Metformin-induced lactic acidosis with emphasis on the anion gap","volume":"28","author":"Blough","year":"2015","journal-title":"Proc (Bayl Univ Med Cent)."},{"issue":"Pt 3","key":"10.1016\/j.ijcard.2024.132338_bb0175","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj3480607","article-title":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain","volume":"348","author":"Owen","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijcard.2024.132338_bb0180","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00125-011-2340-0","article-title":"Metformin-treated patients with type 2 diabetes have normal mitochondrial complex I respiration","volume":"55","author":"Larsen","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.ijcard.2024.132338_bb0185","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.celrep.2019.09.070","article-title":"Metformin improves mitochondrial respiratory activity through activation of AMPK","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijcard.2024.132338_bb0190","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.trsl.2020.10.002","article-title":"Biphasic effect of metformin on human cardiac energetics","volume":"229","author":"Emelyanova","year":"2021","journal-title":"Transl. Res."},{"key":"10.1016\/j.ijcard.2024.132338_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102884","article-title":"Mitochondria in acute myocardial infarction and cardioprotection","volume":"57","author":"Ramachandra","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ijcard.2024.132338_bb0200","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/ejhf.276","article-title":"The prognostic value of arterial blood gas analysis in high-risk acute heart failure patients: an analysis of the Korean heart failure (KorHF) registry","volume":"17","author":"Park","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2024.132338_bb0205","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011450","article-title":"Prognostic value of plasma lactate levels in a retrospective cohort presenting at a university hospital emergency department","volume":"7","author":"van den Nouland","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijcard.2024.132338_bb0210","first-page":"8","article-title":"Metformin affects serum lactate levels in predicting mortality of patients with Sepsis and bacteremia","author":"Chen","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijcard.2024.132338_bb0215","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.ajem.2012.01.014","article-title":"Impact of metformin use on the prognostic value of lactate in sepsis","volume":"30","author":"Green","year":"2012","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.ijcard.2024.132338_bb0220","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/15563650.2013.860985","article-title":"Metformin accumulation: lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy","volume":"52","author":"Vecchio","year":"2014","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.ijcard.2024.132338_bb0225","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2165\/00002018-199920040-00006","article-title":"Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations","volume":"20","author":"Lalau","year":"1999","journal-title":"Drug Saf."},{"key":"10.1016\/j.ijcard.2024.132338_bb0230","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s13181-019-00755-6","article-title":"Do patients die with or from metformin-associated lactic acidosis (MALA)? Systematic review and Meta-analysis of pH and lactate as predictors of mortality in MALA","volume":"16","author":"Blumenberg","year":"2020","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.ijcard.2024.132338_bb0235","volume":"13","author":"Lim","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijcard.2024.132338_bb0240","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011640","article-title":"Metformin use is associated with a lower risk of hospitalization for heart failure in patients with type 2 diabetes mellitus: a retrospective cohort analysis","volume":"8","author":"Tseng","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcard.2024.132338_bb0245","doi-asserted-by":"crossref","first-page":"13038","DOI":"10.1038\/s41598-022-17327-4","article-title":"Metformin treatment is associated with improved outcome in patients with diabetes and advanced heart failure (HFrEF)","volume":"12","author":"Benes","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijcard.2024.132338_bb0250","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3803\/EnM.2021.1046","article-title":"The effects of glucose lowering agents on the secondary prevention of coronary artery disease in patients with type 2 diabetes","volume":"36","author":"Jung","year":"2021","journal-title":"Endocrinol Metab (Seoul)."},{"key":"10.1016\/j.ijcard.2024.132338_bb0255","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cardfail.2009.10.022","article-title":"Metformin therapy and outcomes in patients with advanced systolic heart failure and diabetes","volume":"16","author":"Shah","year":"2010","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2024.132338_bb0260","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jama.290.1.81","article-title":"Metformin and thiazolidinedione use in Medicare patients with heart failure","volume":"290","author":"Masoudi","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2024.132338_bb0265","doi-asserted-by":"crossref","DOI":"10.1177\/1479164120973676","article-title":"Diabetes, metformin and glucose lowering therapies after myocardial infarction: insights from the SWEDEHEART registry","volume":"17","author":"Ritsinger","year":"2020","journal-title":"Diab. Vasc. Dis. Res."},{"key":"10.1016\/j.ijcard.2024.132338_bb0270","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12872-020-01474-5","article-title":"Effect of continuous use of metformin on kidney function in diabetes patients with acute myocardial infarction undergoing primary percutaneous coronary intervention","volume":"20","author":"Yu","year":"2020","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.ijcard.2024.132338_bb0275","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.atherosclerosis.2009.12.015","article-title":"Optimal anthropometric factor cutoffs for hyperglycemia, hypertension and dyslipidemia for the Taiwanese population","volume":"210","author":"Tseng","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2024.132338_bb0280","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/sj.ijo.0803218","article-title":"Body mass index and waist circumference as determinants of coronary artery disease in Taiwanese adults with type 2 diabetes mellitus","volume":"30","author":"Tseng","year":"2006","journal-title":"Int. J. Obes. (Lond)"},{"key":"10.1016\/j.ijcard.2024.132338_bb0285","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ccl.2021.12.009","article-title":"The impact of obesity in heart failure","volume":"40","author":"Carbone","year":"2022","journal-title":"Cardiol. Clin."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324009604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324009604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T18:43:02Z","timestamp":1721932982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527324009604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":57,"alternative-id":["S0167527324009604"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.132338","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preadmission metformin use increased the incidence of hyperlactatemia at admission and 30-day in-hospital mortality among T2D patients with heart disease at high risk of hypoxia","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.132338","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"132338"}}